Condition

Exacerbation Copd clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Exacerbation Copd clinical trials that are recruiting, at sites in 3 countries (most in France (1), Canada (1), Italy (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Exacerbation Copd clinical trials

StudyPhaseWhereStatusRegistered
High-flow nasal cannula versus home mechanical ventilation for COPD patients with persistent high carbon dioxide after an exacerbation — Arezzo and 4 other locations Recruiting Jul 15, 2025
Monitoring end-tidal carbon dioxide levels in COPD exacerbations — Grenoble, Isère and 1 other locations Recruiting Jan 30, 2023
Comparing High Flow Nasal Cannula and Non-Invasive Ventilation for COPD Exacerbations — Toronto, Ontario Recruiting Jan 26, 2017

All recruiting trials (3)

Related topics

Acute Hypercapnic Respiratory FailureCOPDHypercapniaPulmonary Disease, Chronic Obstructive

Quick answers

How many Exacerbation Copd clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in France (1 trial), Canada (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.